Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?-Reference-Cited by-同舟云学术

Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?

Published:2011-03-17 Issue:5 Volume:7 Page:623-642
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Brózik Anna,Hegedüs Csilla,Erdei Zsuzsa,Hegedűs Tamás,Özvegy-Laczka Csilla,Szakács Gergely,Sarkadi Balázs

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.2011.562892

Reference185 articles.

1. Cancer Statistics, 2009

2. Targeting multidrug resistance in cancer

3. Targeted cancer therapy

4. Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IRE1α‐XBP1s axis regulates SREBP1‐dependent MRP1 expression to promote chemoresistance in non‐small cell lung cancer cells;Thoracic Cancer;2024-09-08

2. Epithelial–mesenchymal transition (EMT) and its role in acquired epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) chemoresistance in non-small cell lung cancer (NSCLC);Cancer Pathogenesis and Therapy;2024-07

3. Pharmacology of Tyrosine Kinase Inhibitors;Clinical Journal of the American Society of Nephrology;2023-12-11

4. Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2;Drug Resistance Updates;2023-11

5. How Cryo-EM Has Expanded Our Understanding of Membrane Transporters;Drug Metabolism and Disposition;2023-07-12